Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - amitrole; ammonium thiocyanate - aqueous concentrate - amitrole triazole active 250.0 g/l; ammonium thiocyanate cyanide other 220.0 g/l - herbicide - aquatic weed control | barley - prior to sowing | buildings - around | canola | commercial area - general | corymbia- post plant - african daisy | apple-of-sodom | artichoke thistle | blackberry | bladder ketmia | broadleaf weeds | broadleaf weeds and grasses | caltrop or yellow vine | capeweed | chilean cestrum | clover | common heliotrope | common reed or phragmites | common storksbill | couch grass | creeping/russian knapweed,hardhead | cumbungi | dock | dwarf amaranth or boggabri weed | fennel | flaxleaf fleabane | fleabane | furze or gorse | grass weed | hoary cress or whiteweed | illyrian thistle | khaki weed | kikuyu grass | marsh or smallflower mallow | mouse-ear chickweed | nutgrass | onion weed | ox-eye daisy | paterson's curse | prairie ground cherry | ryegrass | sand brome | silver grass or rat's-tail fescue | sorrel | soursob or oxalis | sow or milk thistle - seedling | spear thistle - seedling | tree pear | volunteer canola - see label for except | volunteer cotton - conventional | volunteer cotton - roundup ready | water couch | water hyacinth | watsonia | wild or black oat | winter grass | yorkshire fog grass | acetosella

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - ketorolac trometamol 5 mg/ml;  ;   - eye drops, solution - 0.5% w/v - active: ketorolac trometamol 5 mg/ml     excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid macrogols purified water sodium chloride sodium hydroxide

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - clopidogrel bisulfate 97.875mg equivalent to clopidogrel 75 mg - film coated tablet - 75 mg - active: clopidogrel bisulfate 97.875mg equivalent to clopidogrel 75 mg excipient: colloidal silicon dioxide dimeticone hydrogenated castor oil hyprolose instacoat universal pink a05g30176 lactose monohydrate - prevention of vascular ischaemia associated with atherothrombotic events (mi, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - clopidogrel bisulfate 97.875mg equivalent to 75 mg clopidogrel;   - film coated tablet - 75 mg - active: clopidogrel bisulfate 97.875mg equivalent to 75 mg clopidogrel   excipient: hydrogenated vegetable oil hyprolose mannitol microcrystalline cellulose opacode black s-1-17823 opadry pink purified water - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - tibolone 2.5mg;   - tablet - 2.5 mg - active: tibolone 2.5mg   excipient: ascorbyl palmitate lactose monohydrate magnesium stearate potato starch - · treatment of symptoms resulting from the natural or surgical menopause in post-menopausal women. women above 60 years of age should only start with livial treatment when they are intolerant of or contraindicated for other medicinal products approved for the treatment of oestrogen deficiency symptoms. · prevention of bone mineral density loss in postmenopausal women at high risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - modafinil 100mg; modafinil 100mg - tablet - 100 mg - active: modafinil 100mg excipient: croscarmellose sodium lactose monohydrate magnesium orthosilicate magnesium stearate maize starch povidone purified talc active: modafinil 100mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone pregelatinised maize starch - · to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy. · to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where non pharmacological interventions are unsuccessful or inappropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - dexamethasone 700ug - intraocular implant - 700 mcg - active: dexamethasone 700ug excipient: polyglactin (poly (d, l-lactide-co-glycolide), 50:50 plga acid) polyglactin - ozurdex® is indicated for the treatment of macular oedema due to retinal vein occlusion (rvo).

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - lenalidomide 10mg;   - capsule - 10 mg - active: lenalidomide 10mg   excipient: capsugel yellow 4035 capsule blue-green 6579 croscarmellose sodium lactose magnesium stearate microcrystalline cellulose tekprint black sw-9008 tekprint black sw-9009 - revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - lenalidomide 15mg;   - capsule - 15 mg - active: lenalidomide 15mg   excipient: capsule blue 3628 capsule white 0999 croscarmellose sodium lactose magnesium stearate microcrystalline cellulose tekprint black sw-9008 tekprint black sw-9009 - revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - lenalidomide 25mg;   - capsule - 25 mg - active: lenalidomide 25mg   excipient: capsule white 0999 croscarmellose sodium lactose magnesium stearate microcrystalline cellulose tekprint black sw-9008 tekprint black sw-9009 - revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.